Dermapharm Holding SE (DB:DMP) entered into a share purchase agreement to acquire Bio-Diat-Berlin Gesellschaft Mit Beschrankter Haftung from a private investor for €15.3 million on September 21, 2017. The purchase price consisted of €15.3 million. Of which, €14.5 million was pre-paid in financial year 2017. As of 31 December 2017, a residual amount of €0.8 million remains as a purchase price liability. Less the cash and cash equivalents acquired, the transaction resulted a cash outflow of €13.7 million resulted in financial year 2017. On September 14, 2017, Dermapharm entered into a €50 million loan agreement with COMMERZBANK AG, as lender. The funds were utilized to finance the acquisition of Bio-Diat-Berlin. Dermapharm Holding SE (DB:DMP) completed the acquisition of Bio-Diat-Berlin Gesellschaft Mit Beschrankter Haftung from a private investor on October 1, 2017.